Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial is a paper indexed in PICO Portal from OpenAlex.
How many citations does Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial have?
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial has 39 citations in the OpenAlex counts PICO Portal stores.
When was Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial published?
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial has 2018 year in the PICO Portal index.
What is the open-access status of Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial?
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial has gold oa status in the PICO Portal index.
What is the DOI of Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial?
The DOI for Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial is on the source record.
What is the PMID of Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial?
The PMID for Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial is on the source record.
What is the OpenAlex record for Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial?
The OpenAlex for Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial is on the source record.